Serum galactomannan assay for diagnosis of probable invasive Aspergillosis in acute leukemia and hematopoietic stem cell transplantation

Indian Journal of Medical and Paediatric Oncology

Volumn 34, Issue 2, 2013, Pages 74-79

  Ghosh, Indranil ^a   Raina, Vinod ^b   Kumar, Lalit ^b   Sharma, Atul ^b   Bakhshi, Sameer ^b   Iqbal, Sobuhi ^b  

^a Tata Medical Centre   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Acute leukemia; computed tomography; galactomannan assay; hematopoietic stem cell transplantation; invasive Aspergillosis

Indexed keywords

AMIKACIN; AMPHOTERICIN B; CYTARABINE; GALACTOMANNAN; ITRACONAZOLE; LEVOFLOXACIN; SULPERAZON;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; ASSAY; CANCER CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INVASIVE ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPTICAL DENSITY; PRIORITY JOURNAL;

EID: 84883272804     PISSN: 09715851     EISSN: 09752129     Source Type: Journal    
DOI: 10.4103/0971-5851.116181     Document Type: Article

References (23)

1. Hope WW, Walsh T J, Denning D W. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005;5:609-22. (Pubitemid 41383906)
2. Walsh T J, Anaissie E J, Denning D W, Herbrecht R , Kontoyiannis D P, Marr KA, et al.. Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-60. (Pubitemid 351265310)
3. T hornton CR. Detection of invasive aspergillosis. Adv Appl Microbiol 2010;70:187-216.
4. Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L , Bijlmer HA, et al.. Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database Syst Rev 2008;4:CD007394.
5. Anjan M, Oberoi J, Yadav SP, Sachdeva A. Diagnosis of invasive aspergillosis using Galactomannan assay in pediatric patients with cancer. J Clin Oncol 2008;26 Suppl 15S: 20522.
6. Hughes WT, Armstrong D , Bodey GP, Bow EJ, Brown AE, Calandra T , et al.. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-51. (Pubitemid 34194843)
7. D e Pauw B, Walsh T J, Donnelly JP, Stevens D A, Edwards JE, Calandra T , et al.. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
8. Adam O, Aupérin A, Wilquin F, Bourhis JH, Gachot B, Chachaty E . Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004;38:917-20. (Pubitemid 38387246)
9. Aubry A, Porcher R , Bottero J, Touratier S, Leblanc T , Brethon B, et al.. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol 2006;44:389-94. (Pubitemid 43222228)
10. Mattei D , Rapezzi D , Mordini N, Cuda F, Lo Nigro C, Musso M, et al.. False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment. J Clin Microbiol 2004;42:5362-3. (Pubitemid 39506257)
11. Walsh T J, Shoham S, Petraitiene R , Sein T , Schaufele R , Kelaher A, et al.. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 2004;42:4744-8. (Pubitemid 39362397)
12. Viscoli C, Machetti M, Cappellano P, Bucci B, Bruzzi P, Van Lint MT, et al.. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004;38:913-6. (Pubitemid 38387245)
13. Bart-Delabesse E , Basile M, Aljijakli A, Souville D , Gay F, Philippe B, et al.. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J Clin Microbiol 2005;43:5214-20. (Pubitemid 41484028)
14. Orlopp K, von Lilienfeld-Toal M, Marklein G, Reiffert SM, Welter A, Hahn-Ast C, et al.. False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: Does it represent a clinical problem.J Antimicrob Chemother 2008;62:1109-12.
15. Boonsarngsuk V, Niyompattama A, Teosirimongkol C, Sriwanichrak K. False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics. Scand J Infect Dis 2010;42:461-8.
16. Zandijk E , Mewis A, Magerman K, Cartuyvels R . False-positive results by the platelia Aspergillus galactomannan antigen test for patients treated with amoxicillin-clavulanate. Clin Vaccine Immunol 2008;15:1132-3. (Pubitemid 352018326)
17. Mori Y, Nagasaki Y, Kamezaki K, Takenaka K, Iwasaki H, Harada N, et al.. High incidence of false-positive Aspergillus galactomannan test in multiple myeloma. Am J Hematol 2010;85:449-51.
18. Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E , et al.. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study. Clin Infect Dis 2005;41:1242-50. (Pubitemid 41534660)
19. Weisser M, Rausch C, Droll A, Simcock M, Sendi P, Steffen I, et al.. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clin Infect Dis 2005;41:1143-9. (Pubitemid 41429477)
20. Miceli MH, Grazziutti ML, Woods G, Zhao W, Kocoglu MH, Barlogie B, et al.. Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: Clinical and research implications. Clin Infect Dis 2008;46:1412-22. (Pubitemid 351589942)
21. Anaissie E J. Trial design for mold-active agents: Time to break the mold-Aspergillosis in neutropenic adults. Clin Infect Dis 2007;44:1298-306. (Pubitemid 46717291)
22. Ji Y, Xu LP, Liu D H, Chen YH, Han W, Zhang XH, et al.. Positive results of serum galactomannan assays and pulmonary computed tomography predict the higher response rate of empirical antifungal therapy in patients undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011;17:759-64.
23. T an BH, Low JG, Chlebicka NL, Kurup A, Cheah FK, Lin RT , et al.. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: A prospective randomized study. Int J Infect Dis 2011;15:e350-6.